Chirag Patel's most recent trade in Amneal Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 733,944 Performance-Based Restricted Stock Units done . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 733,944 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 733,944 | 1,636,239 (1%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 03 Mar 2026 | 297,537 | 1,338,702 (0%) | 0% | 13.3 | 3,960,217 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 92,593 | 1,431,295 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 92,593 | 185,185 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 59,931 | 179,795 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 59,931 | 917,911 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.30 per share. | 03 Mar 2026 | 37,825 | 1,393,470 (0%) | 0% | 13.3 | 503,073 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.31 per share. | 03 Mar 2026 | 15,616 | 902,295 (0%) | 0% | 13.3 | 207,849 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 354,031 | 354,031 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 190,632 | 190,632 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 890,410 | 890,410 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 579,710 | 0 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 579,710 | 1,092,276 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.76 per share. | 03 Mar 2025 | 279,527 | 812,749 (0%) | 0% | 8.8 | 2,448,657 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 239,726 | 239,726 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 92,592 | 905,341 (0%) | 0% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 92,592 | 277,778 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.84 per share. | 03 Mar 2025 | 47,361 | 857,980 (0%) | 0% | 8.8 | 418,671 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 1,333,334 | 1,333,334 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 370,370 | 370,370 | - | - | Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Other type of transaction at price $ 0.00 per share. | 07 Nov 2023 | 21,269,420 | 0 | - | - | Class B Common Stock and Common Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO | Other type of transaction at price $ 0.00 per share. | 07 Nov 2023 | 21,269,420 | 21,269,420 (14%) | 14% | - | Class A Common Stock | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 733,944 | 733,944 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 1,159,420 | 1,159,420 | - | - | Performance-Based Restricted Stock Units | |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.13 per share. | 15 Dec 2021 | 100,000 | 462,566 (0%) | 0% | 4.1 | 413,000 | Class A Common Stock |
| Amneal Pharma Inc (Class A) | Chirag Patel | Director, President & Co-CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 15 Dec 2021 | 50,000 | 512,566 (0%) | 0% | 4.3 | 212,500 | Class A Common Stock |